2nd subcommittee on children: Comments from WHO departments
-
Comments from CAH on: carbapenems, cefalexin, ceftazidime, ceftriaxone, fluoroquinolones, gentamicin, macrolides, procaine benzylpenicillin, sulfadiazine, tetracycline, quinidine, RHD, pancreatic enzymes, salbutamol, neonates
pdf, 672kb -
Comments from HIV/AIDS on antiretrovirals
pdf, 375kb -
Comments from PHE/EPE on antidotes
pdf, 94kb -
NEW -- Comments from Dr J. Alvar, HTM/NTD, on liposomal amphotericin B
pdf, 109kb -
NEW -- Comments from Director, MSD on psychotherapeutic medicines
pdf, 196kb
Contact: emlsecretariat@who.int
Medicine Access and Rational Use (MAR)
20 Avenue Appia
CH-1211 Geneva 27